Colorectal Cancer Therapeutics Market Size, Share, Analysis & Growth Report: 2015 - 2020 Edition

‘Colorectal Cancer (CRC) Therapeutics in Major Developed Markets to 2020 - Increased Uptake of High Priced Drugs to Offset the Impact of Generics’. The report, published by GBI research, is now available for sale on the GBI research website. The study provides exhaustive coverage of the market for colorectal cancer therapeutics in eight developed markets, namely, US, UK, Canada, Germany, France, Italy, Spain, and Japan. The report estimates the size of the colorectal cancer therapeutics market for 2013 and provides forecasts through 2020. The report also covers the epidemiology of the disease, its treatment algorithms and patterns, as well as an analysis of the current pipeline in great detail. The deals landscape of the colorectal cancer therapeutics market is assessed in detail.

Colorectal Cancer Therapeutics in Major Developed Markets to 2020 - Increased Uptake of High Priced Drugs to Offset the Impact of Generics

According to the findings of the research, the CRC therapeutics market is expected to exhibit a CAGR of 1.8%, to touch US$9.4 billion by the end of 2020. Of all markets studied in this report, the United States was the leader in terms of market share as of 2013. In that year, the US’s share equaled 44.1% of the global market, followed at a distance by Japan (14.7%) and Germany (11.9%). At 4.1%, Spain carried the lowest share among the eight countries included in this report.

Japan will experience the fastest rate of growth—5%—among all other countries through the forecast period, the report states. However, Japan’s marginal growth rate will likely be stymied by aggressively-priced biosimilar versions of cetuximab and bevacizumab. This will occur primarily because the patents of Erbitux and Avastin are inching closer to expiration.

During the forecast period of the report, generic versions of the drug capecitabine are expected to be launched; ultimately impacting the market. However, some of this impact will be mitigated by certain emerging therapies—that are priced at a premium—on the horizon.

The team of analysts that produced this report found that the colorectal cancer therapeutics pipeline is teeming with potential drug candidates scattered across several clinical development phases. With approximately 400 molecules in the active pipeline, a preponderance of these drug candidates being investigated are being assessed for advanced-stage CRC – for both first- and second-line therapies.

Global Smartwatches Market Share, Growth, Size & Outlook Report 2020

‘‘ Smartwatches Market [By Price Range - High-end Smartwatches, Mid-end Smartwatches, and Low-end Smartwatches; By Operating System - Android Wear, Watch OS, and Others] - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014-2020 ” to its vast repository. The report, covers the present status and forthcoming opportunities and trends in the market for smartwatches. The report also offers information in the form of illustrative tables and analytical graphs to aid easier comprehension. Company profiles of dominant players across the globe form a pivotal part of the study.

Smartwatches Market [By Price Range - High-end Smartwatches, Mid-end Smartwatches, and Low-end Smartwatches; By Operating System - Android Wear, Watch OS, and Others] - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

According to this report, the global smartwatch market had a total worth of US$701 million in 2013. Evaluating the market's growth prospects, the report concludes that the market will develop at a 53.6% CAGR from the year 2014 to 2020. The report suggests that the market for global smartwatch is bifurcated on the basis of price range and operating systems. Operating systems in the smartwatch market are of two types: Watch OS, Android Wear OS, and others. The other segment, by operating system, encompasses: Firefox OS, Tizen OS, Pebble OS, and LinkIt OS. The study also categorizes the smartwatch market based on pricing. High-end smartwatches, mid-end smartwatches, and low-end smartwatches are the categories of smartwatches elaborated upon in the report.

This study further states that North America was the biggest business sector for smartwatches in terms of revenue, in 2013. The region has a huge selection of advanced and modern smartwatches due to the existence of health-conscious and tech-savvy clients in this region. Health and fitness are predicted to remain the primary applications of smartwatches over the forecasting horizon. This is expected to be complemented by consistently high demand for smartphones from North America.

Moreover, mindfulness among end users and high purchasing power is expected to drive this regional market over the forecast horizon 2014-2020. Europe and Asia Pacific are foreseen to witness sound development over the forecast period. The key companies profiled in this report include Samsung Electronics Co. Ltd., Pebble Technology Corporation, Apple Inc., Garmin Ltd., Sony Electronics Inc., Nike Inc., Fitbit Inc., ConnecteDevice Ltd., Qualcomm Incorporated, and Martian Watches.

Global Asthma Therapeutics Market Report Analysis, Growth,& Outlook 2015 - 2020

Market Research Reports Search Engine (MRRSE) has announced that its repository now features a report titled “ Asthma Therapeutics Market to 2020 – Personalized Treatment for Severe Asthma to Drive Market Growth despite Patent Expirations.” The report, by GBI Research, forecasts that the market for asthma therapeutics will demonstrate marginal CAGR of 2.4% between 2013 and 2020. The forecast, which pertains to the top eight developed nations, estimates that the market will expand from its 2013 value of US$18.4 billion to US$21.7 billion by the end of 2020.

Asthma Therapeutics Market to 2020 - Personalized Treatment for Severe Asthma to Drive Market Growth despite Patent Expirations

Meager as the growth may look, it is important to note that the asthma therapeutics market is on the verge of witnessing widespread generic erosion. Patent expirations are expected to eat into the revenues of blockbuster drugs such as Advair (fluticasone propionate/salmeterol xinafoate), Xolair (omalizumab), and Symbicort (budesonide/formoterol fumarate). This sea change in the global asthma therapeutics market will be brought about by the entry of new players as well as the growing pervasiveness of asthma itself.

The report notes that there is unparalleled industry interest in monoclonal antibodies and biologics, with the former enjoying more attention within the indication. Clinical trials have shown encouraging results for new monoclonal antibodies; some of these include: Lebrikizumab, mepolizumab, dupilumab target Interleukins (IL), and reslizumab. These molecules are seen to be beneficial in inadequately controlled or severe eosinophilic asthma. These drugs, which will constitute a sizeable chunk of the personalized asthma therapeutics market, will target a small section of asthma patients, but will carry steep price tags and still drive market growth. This, market experts predict, will ostensibly offset the detrimental effects of generic erosion.

Healthcare systems worldwide are already heaving the burden of growing incidences of asthma, show figures from the World Health Organization. The disease—which affected an estimated 300 million people worldwide in 2007—is projected to spread to 400 million people by 2025. While the better part of asthma patients are able to bring their symptoms under control using products currently available on the market, there is still a considerable chunk of asthma victims that cannot do so. This unmet need in the global asthma therapeutics market has kindled the interest of pharmaceutical companies and other industry players.

This has proven highly beneficial to the current asthma pipeline, with several promising molecules reported to be on the anvil. A number of these molecules are in the later stages of development and are expected to hit the asthma therapeutics market as early as 2015-16.

Automotive Cockpit Electronics Market Report: Automotive and Transportation

Global Market Study on Automotive Cockpit Electronics: Infotainment and Navigation Segment to Witness Highest Growth by 2020’, the overall market will be worth US$ 61.5 billion by 2020. The report also estimates that the market for automotive cockpit electronics—impelled by an increase in global per capita car ownership—will exhibit a 12.0% CAGR from 2014 through 2020. The market approximated US$31.1 billion in 2013, the report states. The infotainment and navigation segments are on the brink of impressive growth.

Global Market Study on Automotive Cockpit Electronics: Infotainment and Navigation Segment to Witness Highest Growth by 2020

There are several factors that augur well for the automotive cockpit electronics market. These include: Consumers showing heightened interest in purchasing automotive cockpit electronics (coupled with their ability to afford these products), a higher degree of technological innovation being reported from the stables of automotive cockpit electronics manufacturers, and increased investments in R&D in this field. However, the greatest influencer, arguably, is the automotive industry shifting from analog to digital systems.

All of these positives are backed by the estimates of the International Transport Forum, which functions under the aegis of the Organization for Economic Cooperation and Development (OECD), which put the estimated number of cars on the world’s roads at 2.5 billion by the end of 2050. A palpable rise in car ownership numbers has been reported from developing nations in Eastern Europe as well as the Middle East. Germany, which is at the heart of the logistics industry in Europe, is also a country that boasts the largest number of commercial vehicles. Recently, an American advisory firm said that the passenger car sales will likely soar to 116 million by 2020, from 81 million in 2012. In the meanwhile, BRIC nations are showing much promise when it comes to vehicles sales. All of these diverse factors intertwine to create a firm foundation for the growth of the automotive cockpit electronics market.

However, that doesn’t take anything away from the fact that the global automotive cockpit electronics market will have to brave imminent headwinds. For one, the automotive industry hasn’t been able to entirely put the Eurozone crisis behind. The maximum impact of this is being still felt on OEM sales. Nevertheless, several emerging opportunities await manufacturers of automotive cockpit electronics in the immediate future (the TPMS mandate in Europe is one among these).

Global 3D Printing Market Size, Analysis, Share, Growth, Industry Trend & Forecast Report 2015 - 2025

From a niche technology to one that is being touted as the catalyst for the third industrial revolution, 3D printing has been the center of much hype over the last few years. To explore this trend further, ‘ 3D Printing 2015-2025: Technologies, Markets, Players’ to its repository. The report, published by MRRSE, covers the current status and future trends and opportunities in the 3D printing market. The report also offers much information besides in the form of illustrative tables and analytical graphs. Company profiles of leading players across the globe form a pivotal part of the study.

3D Printing 2015-2025:Technologies, Markets, Players

A wide array of technologies is deployed in 3D printing operations, and the report covers the most important ones among these in detail. The report offers forecasts for industries where 3D printing is now widely used. These include: Aerospace, bioprinting, consumer products, automotive, oil and gas, medical, dental, hobbyist, education, and jewelry.

The team of analysts that produced this report expects the mammoth oil and gas industry—which earns trillions of dollars by way of revenues annually—to be the leading emerging user of 3D printing. The aerospace industry, with its ever-increasing demand for high-precision and failsafe components, will also create a rather discernible demand for 3D printing.

According to the report, when 3D printing penetrates the market to a considerable degree, it is these big industries that will bring about the stabilization of 3D printing prices. However, that is not to entirely discount the periodic price fluctuations that will customarily occur as the market progresses. As in the case of conventional CNC machines and tools, growth in the 3D printing market, too, will not be monotonic.

The 3D printing technologies analyzed in the market research report are: Stereolithography, inkjetted photopolymers, digital light processing, thermoplastic extrusion, selective laser melting of metals, selective laser sintering of plastics, welding, binder jetted into metal powder, hybrid CNC, blown metal powder, sand welding, and more. The entire 3D printing landscape is mapped on the basis on the precision of the type of technology, size, precision, as well as price.

By applications, detailed analyses are conducted for: Edutainment, flight-critical component manufacturing, art, mold making for metal casing, tooling, modeling and rapid prototyping.

Global Acetone Market Analysis Report Now Available In MRRSE - Market Research Report 2020

Global Industry Analysis and Opportunity Assessment, 2014–2020’ to its database. The report finds that global acetone consumption stood at 5.9 million tonnes in 2014, and is poised to grow at a meager 3% CAGR from 2014 to 2020 to reach a little over 7.21 million tonnes by 2020. The report has been published by MRRSE.

Acetone Market: Global Industry Analysis and Opportunity Assessment, 2014 - 2020

The key drivers identified by the study are: The chemical sector’s dependence on acetone as a solvent, the use of acetone as a chemical in several processes, and the escalating use of BPA in the global automobile sector. On the other hand, the report warns that hurdles such as increasingly stringent government mandates for the chemical industry and the growing acceptance of bio-based acetone will restrict growth to some degree.

In order to offer highly detailed insights into various facets of the global acetone market, the report dissects each segment of the market into smaller sub-segments. The market, thus segmented, features the following applications of acetone: Methyl methacrylate (MMA), solvent and Bisphenol A (BPA). At 28.3%, the consumption of acetone in the MMA application segment was seen to be the highest as compared to all other applications in 2014. Until 2020, this application will gain a firm foothold in the acetone market, and it is unlikely to be surpassed by any other single application segment.

MMA and BPA together held a combined market share of nearly 60% of the overall acetone consumption as of 2014. Moving forward, until 2020, these two shares will continue to maintain their position in the market, the report states.

The findings of the report also show that robust growth will be seen in the MMA segment through the forecast period thanks to consistent demand for acetone from the electronics and chemicals industries. BPA, on the other hand, is extensively required in the production and processing of spectacle lenses, water bottles, medical equipment, digital media equipment, consumer electronics, cellphones, and other business equipment. All of these factors will be further supplemented by the increasing utilization of acetone in personal care products and an array of household products.

By 2020, Asia Pacific will be the most dominant region in the consumption of acetone. The demand for acetone here is on an upswing in the industrial sector of countries such as China, South Korea, India, Indonesia and Malaysia. The region is already influential in the acetone market, accounting for 41% of the global consumption of acetone in 2014. The share of North America (21%) in the acetone market dwarfs in comparison to APAC. Recently, several major players in the global acetone market reported capacity expansion. It now remains to be seen whether, and how, these enhanced capacities will impact the inherent dynamics of the global acetone market.

Diabetic Nephropathy Market Size: Global Industry Pharmaceutical Market Research Report

Global Market Study on Diabetic Nephropathy Market – Asia to Witness Highest Growth by 2020’. The study says that the diabetic nephropathy market approximated US$2,262.2 million in 2014, and will be worth US$ 3,145.9 million by the end of 2020.

Global Market Study on Diabetic Nephropathy: Asia to Witness Highest Growth by 2020

Diabetic nephropathy, a condition that increase the risk of mortality in diabetes patients, is being widely reported across the world due to the sheer increase in the number of obese people and diabetics. The disease affects the kidneys, ultimately rendering them ineffective. This has necessitated investments in formulating treatments for diabetic nephropathy, leading to a teeming therapy pipeline in major markets of the world.

The drugs, however, are faced with long approval times (essentially because there are scores of regulatory hurdles) making it difficult for pharma companies to bring novel products to the market in short turnaround times. Moreover, there is a general lack of broader therapeutic management for the disease. All of these factors will play a role in curtailing the growth of the global diabetic nephropathy market.

The report notes that North America has the highest degree of awareness about diabetic nephropathy. Government initiatives such as the National Kidney Disease Education Program can be credited for this. The market here continues to organically grow because of a parallel increase in the number of people suffering from diabetes in America. Estimates from the SciELO Public Health state that in 2000 about 35 million people in North America suffered from diabetes mellitus; by 2025, this number will soar to 64 million in the region. The European diabetic nephropathy market is also on an upswing because here too, diabetes is increasingly being reported. International Diabetes Federation (IDF) says that the amount expended on diabetes treatment in the European region was pegged at US$105.5 billion in 2010, and will hit US$124.6 billion by 2030.

The highest potential for growth lies in the Asia Pacific diabetic nephropathy market. The region is witnessing an escalation in the incidence of diabetic nephropathy in Japan and other Southeast Asian nations.

Moving forward, companies in the diabetic nephropathy market have a lucrative opportunity in developing combination therapies.